Sample global coronary stents market (bare metal, drug-eluting, bioresorable)

(c) AZOTH Analytics

November 2016

Global Coronary Stents Market (Bare Metal, Drug-Eluting, Bioresorable): Analysis By Segment, By

Region, By Country (2016-2021)

• By Segment - Bare Metal stents (BMS), Drug-Eluting Stents (DES), Bioresorbable Stents; • By Region - North America, Europe, APAC,

ROW; • By Country - USA, Canada, UK, Germany,

India, Japan, China, Brazil, UAE• Market Entry Strategies for Global Players• Coronary Stents - Pipeline Analysis

(c) AZOTH Analytics

Table of Contents

2

S.No Particulars Page No.

1. Research Methodology 15

2. Executive Summary 16

3. Strategic Recommendations

3.1. Bioresorbable Stents as the Future Market 18

3.2. Focus on Lowering of ASP in Coronary Stents 19

3.3. Opportunities in APAC Region 20

4. Global Coronary Stents Market: An Overview

4.1. Product Overview 21

4.2. Global Coronary Stents Market 27

4.2.1. By Value (Historic 2011-15) 28

4.2.2. By Value ( Forecast 2016E-2021F) 28

4.3. Global Coronary Stent Market, By Segments 31

4.3.1. In Percentage (2015) 31

4.3.2. In Percentage (2021F) 31

4.4. Global Bare Metal Stents, By Value 32



4.5. Global Drug Eluting Stents, By Value 33

(c) AZOTH Analytics

Table of Contents

3

S. No Particulars Page No.

4.5.1. By Value (Historic 2011-15) 334.5.2. By Value ( Forecast 2016E-2021F) 33

4.6. Global Bioresorbable Stents Market, By Segments 344.6.1. By Value (Historic 2011-15) 344.6.2. By Value ( Forecast 2016E-2021F) 34

4.7. Global Coronary Stent Market, By Region 354.7.1. In Percentage (2015) 354.7.2. In Percentage (2021F) 35

4.8. Coronary Stents : Pipeline Analysis 365. North America Coronary Stent Market: An Overview 44

5.1. North America Coronary Stent Market , By Value 45

5.1.1. By Value (Historic 2011-15) 455.1.2. By Value ( Forecast 2016E-2021F) 45

5.2. North America Bare Metal Stent Market , By Value 495.2.1. By Value (Historic 2011-15) 495.2.2. By Value ( Forecast 2016E-2021F) 49

5.3. North America Drug Eluting Stent Market , By Value 505.3.1. By Value (Historic 2011-15) 505.3.2. By Value ( Forecast 2016E-2021F) 50

5.4. North America Bioresorbable Stent Market , By Value 51

(c) AZOTH Analytics

Table of ContentsS. No Particulars Page

No.

5.4.1. By Value ( 2011-2021F) 515.5. North America Coronary Stent Market, By Country , By Percentage 52

5.5.1. In Percentage (2015) 525.5.2. In Percentage (2021F) 52

5.6. North America Coronary Stent Market, By Country (USA, Canada) (2011-2021F) 535.5.1. USA Coronary Stents Market, By Value 54

5.5.1.1. By Value ( 2011-2021F) 545.5.1. Canada Coronary Stents Market, By Value 59

5.5.1.1. By Value ( 2011-2021F) 596. Europe Coronary Stent Market: An Overview 61

6.1. Europe Coronary Stent Market , By Value 626.1.1. By Value (Historic 2011-15) 626.1.2. By Value ( Forecast 2016E-2021F) 62

6.2. Europe Bare Metal Stent Market , By Value 656.2.1. By Value (Historic 2011-15) 656.2.2. By Value ( Forecast 2016E-2021F) 65

6.3. Europe Drug Eluting Stent Market , By Value 666.3.1. By Value (Historic 2011-15) 666.3.2. By Value ( Forecast 2016E-2021F) 66

4

(c) AZOTH Analytics


No.6.4. Europe Bioresorbable Stent Market , By Value 67

6.4.1 By Value (Historic 2012-15) 676.4.2. By Value ( Forecast 2016E-2021F) 67

6.5. Europe Coronary Stent Market, By Country , By Percentage 686.5.1. In Percentage (2015) 686.5.2. In Percentage (2021F) 68

6.6. Europe Coronary Stent Market, By Country (UK, Germany(2011-2021F) 696.6.1. UK Coronary Stents Market, By Value 70

6.6.1.1. By Value ( 2011-2021F) 706.6.2. Germany Coronary Stents Market, By Value 73

6.6.2.1. By Value ( 2011-2021F) 737. APAC Coronary Stent Market: An Overview 76

7.1. APAC Coronary Stent Market , By Value 777.1.1. By Value (Historic 2011-15) 777.1.2. By Value ( Forecast 2016E-2021F) 77

7.2. APAC Bare Metal Stent Market , By Value 807.2.1. By Value (Historic 2011-15) 807.2.2. By Value ( Forecast 2016E-2021F) 80

7.3. APAC Drug Eluting Stent Market , By Value 817.3.1. By Value (Historic 2011-15) 81

5

(c) AZOTH Analytics


No.7.3.2. By Value ( Forecast 2016E-2021F) 81

7.4. APAC Bioresorbable Stent Market , By Value 827.4.1. By Value ( Forecast 2011-2021F) 82

7.5. APAC Coronary Stent Market, By Country , By Percentage 837.5.1. In Percentage (2015) 837.5.2. In Percentage (2021F) 83

7.6. APAC Coronary Stent Market, By Country (China, Japan, India(2011-2021F) 847.6.1. China Coronary Stents Market, By Value 85

7.6.1.1. By Value ( 2011-2021F) 857.6.2. Japan Coronary Stents Market, By Value 88

7.6.2.1. By Value ( 2011-2021F) 887.6.3. India Coronary Stents Market, By Value 91

7.6.3.1. By Value ( 2011-2021F) 918. ROW Coronary Stent Market: An Overview 94

8.1. ROW Coronary Stent Market , By Value 958.1.1. By Value (Historic 2011-15) 958.1.2. By Value ( Forecast 2016E-2021F) 95

8.2. ROW Bare Metal Stent Market , By Value 988.2.1. By Value (Historic 2011-15) 988.2.2. By Value ( Forecast 2016E-2021F) 98

6

(c) AZOTH Analytics

Table of ContentsS. No Particulars Page No.

8.3. ROW Drug Eluting Stent Market , By Value 99



8.4. ROW Bioresorbable Stent Market , By Value 100

8.4.1. By Value ( Forecast 2012-2021F) 100

8.5. ROW Coronary Stent Market, By Country , By Percentage 101

8.5.1. In Percentage (2015) 101

8.5.2. In Percentage (2021F) 101

8.6. ROW Coronary Stent Market, By Country (Brazil, UAE) (2011-2021F) 102

Brazil Coronary Stents Market, By Value 102

8.6.1.1. By Value ( 2011-2021F) 102

UAE Coronary Stents Market, By Value 104

8.6.2.1. By Value ( 2011-2021F) 104

9. Market Dynamics

9.1. Trends 108

9.2. Drivers 114

9.3. Challenges 118

10. Pricing Structure 120

7

(c) AZOTH Analytics

Table of ContentsS. No Particulars Page No.

11. Policy and Regulatory Land scape 12312. M&A and Licensing Route to the Coronary Stents Market 12913. SWOT Analysis 13614. Porter Five Force Model 13715. Product Benchmarking 14016. Company Profiling 141

16.1. Terumo Corporation 14216.2. Boston Scientific 14516.3. Stentys SA 14716.4. MicroPort Scientific Corporation 14816.5. Biotronik 15016.6. Elixir Medical Corporation 15116.7. Biosensors Inc. 15216.8. Medtronic 15316.9. Abbott Laboratories 15516.10. Kyoto Medical Planning 157

17. About Us and Disclaimer 158

8

(c) AZOTH Analytics

List of FiguresFigure No. Figure Title Page No.

Figure 1: Global Coronary Stent Market Size, By Value, 2011-2021F (USD Billion) 28Figure 2: Number of Annual Deaths Due to Cardiovascular Diseases 29Figure 3: Life and Non Life Insurance Penetration in Select Countries 2015 in Percentage 30Figure 4: Global Coronary Stent Market Segment Share 2015 In Percentage 31Figure 5: Global Coronary Stent Market Segment Share 2021 In Percentage 31Figure 6: Global Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Billion 32Figure 7: Global Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Billion 32Figure 8: Global Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion 33Figure 9: Global Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion 33

Figure 10: Global Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million 34Figure 11: Global Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million 34Figure 12: Global Coronary Stent Market Region Share 2015 In Percentage 35Figure 13: Global Coronary Stent Market Region Share 2021 In Percentage 35Figure 14: North America Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion 45Figure 15: North America Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion 45Figure 16: Payment for Cardiology Services in USA 48

Figure 17: North America Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million 49Figure 18: North America Bare Metal Stent Market By Value , Forecast(2016E-2021F) in USD Million 49

Figure 19: North America Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion 50

9

(c) AZOTH Analytics

List of FiguresFigure No. Figure Title Page No.Figure 20: North America Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion 50Figure 21: North America Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million 51Figure 22: North America Coronary Stent Market, By Country – 2015(%) 52Figure 23: North America Coronary Stent Market, By Country – 2021F(%) 52Figure 24: USA Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion 54Figure 25: USA Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion 54Figure 26: Percentage of Population Suffering From Cardiovascular Disease in USA (2009-2012) 56Figure 27: Direct and Indirect Costs Associated With Major Heart Diseases in USA (USD Billion) (2009-2012) 56Figure 28: Canada Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 59Figure 29: Canada Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 59Figure 30: Europe Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion 62Figure 31: Europe Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion 62Figure 32: Cost of CVD in 2014 in some European Countries 63Figure 33: Europe Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million 65Figure 34: Europe Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Million 65Figure 35: Europe Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion 66Figure 36: Europe Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion 66Figure 37: Europe Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million 67Figure 38: Europe Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million 67Figure 39: Europe Coronary Stent Market, By Country – 2015(%) 68Figure 40: Europe Coronary Stent Market, By Country – 2021F(%) 68

10

(c) AZOTH Analytics


Figure 41: UK Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 70Figure 42: UK Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 70Figure 43: Germany Coronary Stents Market, By Value , Historic(2011-2015) in USD Million 73Figure 44: Germany Coronary Stents Market By Value , Forecast(2016E-2021F) in USD Million 73Figure 45: Others Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 75Figure 46: Others Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 75Figure 47: APAC Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion 77Figure 48: APAC Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion 77Figure 49: APAC Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million 80Figure 50: APAC Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Million 80Figure 51: APAC Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Million 81Figure 52: APAC Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Million 81Figure 53: APAC Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million 82Figure 54: APAC Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million 82Figure 55: APAC Coronary Stent Market, By Country – 2015(%) 83Figure 56: APAC Coronary Stent Market, By Country – 2021F(%) 83Figure 57: China Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 85Figure 58: China Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 85Figure 59: Japan Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 88Figure 60: Japan Coronary Market By Value , Forecast(2016E-2021F) in USD Million 88

11

(c) AZOTH Analytics


Figure 61: India Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 91Figure 62: India Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 91Figure 63: ROW Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 93Figure 64: ROW Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 93Figure 65: ROW Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 95Figure 66: ROW Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 95Figure 67: ROW Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million 98Figure 68: ROW Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Million 98Figure 69: ROW Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion 99Figure 70: ROW Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion 99Figure 71: ROW Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million 100Figure 72: ROW Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million 100Figure 73: ROW Coronary Stent Market, By Country – 2015(%) 101Figure 74: ROW Coronary Stent Market, By Country – 2021F(%) 101Figure 75: Brazil Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 102Figure 76: Brazil Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 102Figure 77: UAE Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 104Figure 78: UAE Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 104Figure 79: Causes of Death in UAE 105Figure 80: Others Coronary Stent Market, By Value , Historic(2011-2015) in USD Million 106

12

(c) AZOTH Analytics

List of Figures and TablesFigure No. Figure Title Page No.

Figure 81: Others Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million 106

Figure 82: Average Price of Bare-metal stents 121

Figure 83: Average Price of Drug Eluting stents 122

Figure 84: Cardiac And Vascular Business, By Segment-2015 143

Figure 85: Cardiac And Vascular Business, By Geography - 2015 143

Figure 86: Revenue, By Segment-2015 (in Percentage) 146

Figure 87: Revenue, By Geography - 2015 146


Figure 89: Revenue, By Geography - 2015 149


Figure 91: Cardiac and Vascular Group Revenue, By Geography - 2015 154


Figure 93: Overall Revenue, By Geography - 2015 156

13

Table No. Table Title Page No.

Table 1: Number of Physicians in Cardiology in Canada in 2016 60

Table 2: Average Price of Bare-metal stents 121

Table 3: Average Price of Drug Eluting stents 122

Table 4: Cardio and Vascular Business Revenue By Segment (in USD Billion) 144

(c) AZOTH Analytics 14

Coronary Stents Market (2011-15)


Breakdown-By Stent Type

Bare Metal Stent Market (2011-15)

Bare Metal Stent Market (2016-21)

Drug Eluting Market (2011-2015)

Drug Eluting Market (2016-2021)

Bioresorbable Stent Market (2011-2015)

Bioresorbable Stent Market (2016-2021)

Global Coverage Regional Coverage

Global Coronary Stents Market - Stent Type (Bare Metal Stent, Drug Eluting Stent, Bioresorbable Stent): Analysis By Region, By Country (2016-2021)

Coronary Stents Market (2011-15) Coronary Stents Market (2016-21) Coronary Stents Market : By Stent

Type (2011-15) Coronary Stents Market : By Stent

Type (2016-21)

North America Europe Asia Pacific ROW

Country Coverage



U.S. Canada U.K. Germany China Japan India Brazil UAE

Company Coverage

Product Benchmarking Policy and Regulatory

Landscape Financial Analysis

Sales Business Strategy Market Entry Strategy

Boston Scientific Stentys Terumo Microport Biotronik Abbott Medtronic Elixir Medical Kyoto Medical Planning Biosensors Inc.

Global Coverage Regional Coverage Country Coverage

Scope of the Study Segment Coverage Stent Type (Bare Metal Stent, Drug

Eluting Stent, Bioresorbable Stent)

Market TrendsCompany Analysis

(c) AZOTH Analytics

Research Methodology

Research Definition

• The present report presents the in depth study of global coronary stent market. The market has been segmented by bare

metal stents, drug eluting stents and bioresorbable stents. Regional Analysis consists of four major regions- North America,

Europe, Asia-pacific , and Rest of the world including countries – U.S., Canada, Germany , France , China, India, Japan ,Brazil

etc.• Data Analysis and Interpretation

• Our historic market trend has been figured out by various paid databases which was further triangulated with inputs and

insights from industry experts, companies and stakeholders, through primary research (marketing managers, BDE, Zonal

Managers). Back-of-the-Envelope calculation for the market estimation has been made through proper understanding of the

market as well as future business strategies of the companies operating in the market.Azoth Analytics has conducted quantitative as well as qualitative research to gather market insights such as market sizing, market

segmentation, recent trends and developments and competitive landscape. Our team has conducted extensive primary surveys by

reaching out industry experts across the value chain of the global coronary stent market

For Forecasting purpose we have accessed some of the paid databases such as Bloomberg, Reuters, Factiva, Hoovers etc. Companies Contacted Abbott Laboratories, Medtronic, Biotronik, Boston Scientific, Terumo Corporation

15

(c) AZOTH Analytics

Global Bare Metal Stent Market , By Value

16

2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021

CAGR: x%CAGR: x%

Figure 6 : Global Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Billion

Figure 7 : Global Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Billion

• Bare Metal stents have been witnessing decline over the years considering the stent metal have been used for scaffolding purpose and

widen the gap between the coronary arteries. However, the metal used was known to cause inflammation. Also, these stents had a

high rate of restenosis, which led to frequent re-stenting procedures. With the adoption of DES, these stents have been slowly shifting

towards lesser growth. However, they are still prominent as they are economically priced or used on patients who are ineligible for

DES.

Source: Azoth Analytics

(c) AZOTH Analytics

Global Drug Eluting Stent Market , By Value

17

2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021

CAGR: x%CAGR: x%

Figure 8 : Global Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion

Figure 9 : Global Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion

• Market for DES is highly dominating as they constituted of the drugs that reduced or delayed the need for restenosis, and prevented

the need for re-stenting. Thus, these stents have gained traction over the years, and acceptance by medical associations and

cardiologists supported the demand for DES. Overtime, they have been shifted to biodegradable polymer. However, while they were

effective in delay of restonisis, they were known to cause late thrombosis, as well as vasomotion. The market is expected to remain

stable in the forecast period, due to their high adoption.


(c) AZOTH Analytics

Global Bioresorbable Stent Market , By Value

18

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021

CAGR: x%CAGR: x%

Figure 10 : Global Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million

Figure 11 : Global Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million

• Bioresorbable stents are known to dissolve completely within the body in short span of 2-3 years. Technological innovation and growing

compatibility through clinical trials has led to the high demand for bioresorbable stents. The market is expected to witness

tremendous growth in the forecast period on the back of FDA approval of these stents in USA, leading to a high demand for stent

procedures using these stents.


(c) AZOTH Analytics

About Azoth Analytics Pvt Ltd.Azoth Analytics creates in-depth research reports by recording, interpreting and analyzing information through primary and secondary research. Our strategic market sizing and data dredging techniques include secondary research, interviews with key market players and industry experts and use of industry specific statistical tools which helps in designing and planning effective research for our global and local clients. We provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, retail, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors .

Related Reports:

Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics

therefore, takes no responsibility for any incorrect information supplied to us by industry experts, manufacturers or users. Azoth does not

warranty the completeness of the information and data. Also, analysis provided in the report are meant for customers’ internal use only

and not for general publication or disclosure to third parties.

19

(c) AZOTH Analytics

Report Ordering

(+91) 987 342 6288 (+91) 120 429 8235

[email protected] www.azothanalytics.com

Report Title: Global Chemical Sensors Market (Optical, Electrochemical, Biochemical): Analysis By Type, By Application, By Region, By Country (2016-2021) – By Type (Electrochemical, Optical Chemical, Biochemical and Other); By Application (Medical, Automotive, Environmental Monitoring and Other); By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, China, India, Japan, Brazil and Saudi Arabia)

Published: December 2016 Pages: 162 Price: USD 2400 (Single User License) Price: USD 3000 (Multi- User License)

To View Sample Report or Purchase Report Click Here

Contact us if you have any query

http://www.azothanalytics.com/

http://azothanalytics.com/report/chemicals/global-chemical-sensors-market-optical-electrochemical-biochemical-analysis-by-type-by-application-by-region-by-country-2016-2021-r1073

Sample global coronary stents market (bare metal, drug-eluting, bioresorable)

Health & Medicine

Transcript of Sample global coronary stents market (bare metal, drug-eluting, bioresorable)